{
  "trial_id": "NCT00633542",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "newly diagnosed or advanced multiple myeloma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "minimal response after induction with ThaDD regimen",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "peripheral neuropathy >= grade 2",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "neutropenia < 1000/mcl or thrombocytopenia < 50000/mcl",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "severe depression",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "organ disfunction > grade 2",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has multiple myeloma with systemic amyloidosis and is on hemodialysis. She was treated with various regimens, including ThaDD, but had worsening edema and kidney function.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00633542",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}